International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations.

2.50
Hdl Handle:
http://hdl.handle.net/10541/79045
Title:
International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations.
Authors:
Kaufmann, Manfred; Von Minckwitz, Gunter; Smith, Roy; Valero, Vicente; Gianni, Luca; Eiermann, Wolfgang; Howell, Anthony ( 0000-0002-3879-5991 ) ; Costa, Serban Dan; Beuzeboc, Philippe; Untch, Michael; Blohmer, Jens-Uwe; Sinn, Hans-Peter; Sittek, Rolf; Souchon, Rainer; Tulusan, Augustinos H; Volm, Tanja; Senn, Hans-Jörg
Abstract:
Primary systemic therapy (PST) represents the standard of care in patients with locally advanced breast cancer. In addition, there is increasing information on PST in operable breast disease that supports the use of PST in routine practice. However, current regimens and techniques vary. To address this concern, a group of representatives from breast cancer clinical research groups in France, Germany, Italy, the United Kingdom, and the United States reviewed all available data on prospective randomized trials in this setting. Recommendations are made regarding terminology, indications, regimen, diagnosis before treatment, monitoring of efficacy, tumor localization, surgery, pathologic evaluation, and postoperative treatment.
Affiliation:
Department of Gynecology and Obstetrics, Goethe University, Frankfurt am Main, Germany. M.Kaufmann@em.uni-frankfurt.de
Citation:
International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations. 2003, 21 (13):2600-8 J. Clin. Oncol.
Journal:
Journal of Clinical Oncology
Issue Date:
1-Jul-2003
URI:
http://hdl.handle.net/10541/79045
DOI:
10.1200/JCO.2003.01.136
PubMed ID:
12829681
Language:
en
ISSN:
0732-183X
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorKaufmann, Manfred-
dc.contributor.authorVon Minckwitz, Gunter-
dc.contributor.authorSmith, Roy-
dc.contributor.authorValero, Vicente-
dc.contributor.authorGianni, Luca-
dc.contributor.authorEiermann, Wolfgang-
dc.contributor.authorHowell, Anthony-
dc.contributor.authorCosta, Serban Dan-
dc.contributor.authorBeuzeboc, Philippe-
dc.contributor.authorUntch, Michael-
dc.contributor.authorBlohmer, Jens-Uwe-
dc.contributor.authorSinn, Hans-Peter-
dc.contributor.authorSittek, Rolf-
dc.contributor.authorSouchon, Rainer-
dc.contributor.authorTulusan, Augustinos H-
dc.contributor.authorVolm, Tanja-
dc.contributor.authorSenn, Hans-Jörg-
dc.date.accessioned2009-08-28T10:07:39Z-
dc.date.available2009-08-28T10:07:39Z-
dc.date.issued2003-07-01-
dc.identifier.citationInternational expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations. 2003, 21 (13):2600-8 J. Clin. Oncol.en
dc.identifier.issn0732-183X-
dc.identifier.pmid12829681-
dc.identifier.doi10.1200/JCO.2003.01.136-
dc.identifier.urihttp://hdl.handle.net/10541/79045-
dc.description.abstractPrimary systemic therapy (PST) represents the standard of care in patients with locally advanced breast cancer. In addition, there is increasing information on PST in operable breast disease that supports the use of PST in routine practice. However, current regimens and techniques vary. To address this concern, a group of representatives from breast cancer clinical research groups in France, Germany, Italy, the United Kingdom, and the United States reviewed all available data on prospective randomized trials in this setting. Recommendations are made regarding terminology, indications, regimen, diagnosis before treatment, monitoring of efficacy, tumor localization, surgery, pathologic evaluation, and postoperative treatment.en
dc.language.isoenen
dc.subjectCancer Stagingen
dc.subjectBreast Canceren
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols-
dc.subject.meshBreast Neoplasms-
dc.subject.meshEvidence-Based Medicine-
dc.subject.meshFemale-
dc.subject.meshHumans-
dc.subject.meshInternational Cooperation-
dc.subject.meshNeoadjuvant Therapy-
dc.subject.meshNeoplasm Staging-
dc.subject.meshPatient Selection-
dc.subject.meshRandomized Controlled Trials as Topic-
dc.titleInternational expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations.en
dc.contributor.departmentDepartment of Gynecology and Obstetrics, Goethe University, Frankfurt am Main, Germany. M.Kaufmann@em.uni-frankfurt.deen
dc.identifier.journalJournal of Clinical Oncologyen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.